Patent · US Active

Method for predicting the risk of developing a colonic neoplasia

US9410955B2 · kind B2 · utility

0Cited by

3References

4Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
UNIVERSITE PAUL SABATIER—TOULOUSE III · FR
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE · FR

Inventors

Catherine Seva · Toulouse, FR
Catherine Do · Toulouse, FR
Audrey Ferrand · Toulouse, FR
Julien Palasse · Toulouse, FR
Marie-Bernadette Delisle · Toulouse, FR

Key dates

Filing date	May 31, 2012
Grant date	Aug 9, 2016
Priority date	—
Expiry date	May 31, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/50
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to an in vitro method for determining whether a patient having hyperplastic polyps is at risk of developing a colonic neoplasia after resection of said hyperplastic polyps, said method comprising the step of determining the level of progastrin expression in a tissue sample of a hyperplastic polyp obtained from said patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.